
Tetrahedron Letters p. 3165 - 3168 (1995)
Update date:2022-08-03
Topics:
Harusawa, Shinya
Murai, Yoshihiko
Moriyama, Hideki
Ohishi, Hirofumi
Yoneda, Ryuji
Kurihara, Takushi
A highly stereoselective synthesis of the novel 4-(β-D-ribofuranosyl)imidazole 5 was accomplished in 4 steps and 85 percent overall yield from protected D-ribose 1.Cyclization of the diol (RS)-3 having an intact imidazole by modified Mitsunobu reaction exclusively afforded benzylated β-ribofuranosylimidazole β-4a, accompanied by α-4a, in a ratio of 26:1.Reductive debenzylation completed the synthesis. 2'-Deoxy derivative 8 was also synthesized stereoselectively in the same manner.
View MoreJinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Contact:86-21-58226973
Address:No 351,Guoshoujing Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Nanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
Doi:10.1021/jo01272a014
(1968)Doi:10.1021/om00010a048
(1995)Doi:10.1016/j.molcatb.2013.09.024
(2013)Doi:10.1271/bbb.60590
(2007)Doi:10.1016/j.bmc.2004.07.016
(2004)Doi:10.1016/00404-0399(50)0886H-
(1995)